Furthermore, over half of the 133 putative Flii binding partners identified by immunoprecipitation and LC-MS/MS analysis in the H1299 lung cancer cell line are associated with nucleocytoplasmic transport of both RNA and protein, post-translational modifications of RNA and the biosynthesis of protein (Wang et al., 2017). This evidence concerns the gene FLII and lung carcinoma.